Detalles de la búsqueda
1.
Safety of Long-term Treatment With Certolizumab Pegol in Patients With Crohn's Disease, Based on a Pooled Analysis of Data From Clinical Trials.
Clin Gastroenterol Hepatol
; 14(12): 1753-1762, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27464588
2.
Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study.
Gastroenterology
; 145(2): 329-38.e1, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23583433
3.
A Phase 2b, Randomised, Double-blind, Placebo-controlled, Parallel-arm, Multicenter Study Evaluating the Safety and Efficacy of Tesnatilimab in Patients with Moderately to Severely Active Crohn's Disease.
J Crohns Colitis
; 17(8): 1235-1251, 2023 Aug 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36939629
4.
Challenges in Using Real-world Clinical Practice Records for Validation of Clinical Trial Data in Inflammatory Bowel Disease: Lessons Learned.
Inflamm Bowel Dis
; 24(1): 2-4, 2017 12 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-29272481
5.
From historical perspectives to modern therapy: a review of current and future biological treatments for Crohn's disease.
Therap Adv Gastroenterol
; 8(3): 143-59, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25949527
Resultados
1 -
5
de 5
1
Próxima >
>>